BA
VNDA icon

BlackRock Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

BlackRock Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.57M Sell
98,236
-427
-0.4% -$6.86K ﹤0.01% 1630
2016
Q3 		$1.64M Buy
98,663
+1,907
+2% +$25.7K ﹤0.01% 1560
2016
Q2 		$1.08M Buy
96,756
+77,051
+391% +$746K ﹤0.01% 1729
2016
Q1 		$165K Buy
19,705
+1,459
+8% +$12K ﹤0.01% 2664
2015
Q4 		$170K Sell
18,246
-8,204
-31% -$81.9K ﹤0.01% 2654
2015
Q3 		$298K Sell
26,450
-605
-2% -$7.4K ﹤0.01% 2503
2015
Q2 		$343K Buy
27,055
+5,150
+24% +$55.5K ﹤0.01% 2452
2015
Q1 		$204K Buy
21,905
+329
+2% +$3.72K ﹤0.01% 2662
2014
Q4 		$309K Buy
21,576
+1,403
+7% +$16.6K ﹤0.01% 2346
2014
Q3 		$209K Sell
20,173
-681
-3% -$8.93K ﹤0.01% 2580
2014
Q2 		$337K Sell
20,854
-11,932
-36% -$159K ﹤0.01% 2304
2014
Q1 		$533K Sell
32,786
-28,329
-46% -$403K ﹤0.01% 1996
2013
Q4 		$758K Buy
61,115
+40,482
+196% +$407K ﹤0.01% 1705
2013
Q3 		$226K Sell
20,633
-43,203
-68% -$462K ﹤0.01% 2473
2013
Q2 		$516K Buy
+63,836
New +$430K ﹤0.01% 1801

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors's VNDA Position: Q4 2016 in Review

BlackRock Advisors reduced its Vanda Pharmaceuticals (VNDA) stake by 0.43% in Q4 2016, selling an estimated $6.86K and leaving 98,236 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

BlackRock Advisors first reported a position in VNDA in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.64M in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • BlackRock Advisors held 98,236 shares of Vanda Pharmaceuticals worth $1.57M as of Q4 2016.
  • BlackRock Advisors sold 427 Vanda Pharmaceuticals shares in Q4 2016, an estimated $6.86K.
  • Vanda Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1630 holding.
  • BlackRock Advisors first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Vanda Pharmaceuticals position peaked at $1.64M in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.